{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:22:31Z","timestamp":1790205751074,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.lpm.2014.03.034","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T01:01:52Z","timestamp":1414026112000},"page":"1359-1367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Prise en charge des exacerbations\u00a0: de la ville \u00e0 l\u2019h\u00f4pital"],"prefix":"10.1016","volume":"43","author":[{"given":"St\u00e9phane","family":"Jouneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Brinchault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Desrues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.03.034_bib0005","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.03.034_bib0010","article-title":"Prise en charge de la BPCO: recommandations pour la pratique clinique","volume":"27","author":"Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise","year":"2010","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.lpm.2014.03.034_bib0015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0020","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS medicine"},{"key":"10.1016\/j.lpm.2014.03.034_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1741-7015-11-181","article-title":"Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease","volume":"11","author":"Wedzicha","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0030","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1183\/09031936.00180312","article-title":"High-risk patients following hospitalisation for an acute exacerbation of COPD","volume":"42","author":"Piquet","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0035","series-title":"Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care","author":"NICE. National Clinical Guideline Centre","year":"2010"},{"key":"10.1016\/j.lpm.2014.03.034_bib0040","doi-asserted-by":"crossref","first-page":"136S","DOI":"10.1378\/chest.121.5_suppl.136S","article-title":"Exacerbations: etiology and pathophysiologic mechanisms","volume":"121","author":"Wedzicha","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2014.03.034_bib0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0050","first-page":"S65","article-title":"Recommandations pour la prise en charge de la BPCO\u00a0: antibioth\u00e9rapie des exacerbations\/d\u00e9compensations","volume":"20","author":"Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise","year":"2003","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.lpm.2014.03.034_bib0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-144-6-200603210-00005","article-title":"Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors","volume":"144","author":"Tillie-Leblond","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1183\/09059180.00008612","article-title":"Comorbidities of COPD","volume":"22","author":"Cavailles","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.lpm.2014.03.034_bib0070","doi-asserted-by":"crossref","first-page":"e37483","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"Agusti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2014.03.034_bib0075","first-page":"S56","article-title":"Recommandations pour la prise en charge de la BPCO\u00a0: exacerbations: diagnostic, s\u00e9v\u00e9rit\u00e9 et prise en charge","volume":"20","author":"Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise","year":"2003","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.lpm.2014.03.034_bib0080","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/rccm.200310-1443OC","article-title":"Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease","volume":"169","author":"Wilkinson","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","article-title":"European Respiratory Society Guidelines on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0095","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1183\/09031936.00042111","article-title":"Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis","volume":"39","author":"Miravitlles","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1164\/ajrccm.154.2.8756814","article-title":"Controlled trial of oral prednisone in outpatients with acute COPD exacerbation","volume":"154","author":"Thompson","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0105","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa023161","article-title":"Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease","volume":"348","author":"Aaron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0110","series-title":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Executive summary","author":"National Heart Lung and Blood Institute, NIH and World Health Organization","year":"2014"},{"key":"10.1016\/j.lpm.2014.03.034_bib0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1034\/j.1399-3003.1999.14d34.x","article-title":"Oxygen therapy during exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Agusti","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0120","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(00)04049-6","article-title":"Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease","volume":"357","author":"Moloney","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.03.034_bib0125","first-page":"CD003900","article-title":"Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease","volume":"4","author":"McCrory","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2014.03.034_bib0130","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","article-title":"Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group","volume":"340","author":"Niewoehner","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0135","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","article-title":"Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial","volume":"354","author":"Davies","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.03.034_bib0140","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2013.5023","article-title":"Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial","volume":"309","author":"Leuppi","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2014.03.034_bib0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lpm.2014.03.034_bib0150","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/600122","article-title":"Ciprofloxacin dosage and emergence of resistance in human commensal bacteria","volume":"200","author":"Fantin","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2014.03.034_bib0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0160","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1183\/09031936.00003309","article-title":"Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study","volume":"34","author":"Garcia-Vidal","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1843.2006.00999.x","article-title":"Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa","volume":"12","author":"Lin","year":"2007","journal-title":"Respirology"},{"key":"10.1016\/j.lpm.2014.03.034_bib0170","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","article-title":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial","volume":"363","author":"Christ-Crain","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.03.034_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","article-title":"Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2014.03.034_bib0180","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1183\/09031936.00079111","article-title":"Rehabilitation and acute exacerbations","volume":"38","author":"Burtin","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-138-11-200306030-00007","article-title":"Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation?. A systematic review of the literature","volume":"138","author":"Keenan","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0190","doi-asserted-by":"crossref","first-page":"31s","DOI":"10.1183\/09031936.03.00050403","article-title":"Mechanical ventilation: invasive versus noninvasive","volume":"47","author":"Brochard","year":"2003","journal-title":"Eur Resp J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0195","series-title":"Conf\u00e9rence de consensus\u00a0: ventilation non invasive au cours de l\u2019insuffisance respiratoire aigu\u00eb (nouveau-n\u00e9 exclu)","author":"Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie-r\u00e9animation (SFAR), Soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise (SPLF) et la Soci\u00e9t\u00e9 de r\u00e9animation de langue fran\u00e7aise (SRLF)","year":"2006"},{"key":"10.1016\/j.lpm.2014.03.034_bib0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/bmj.38159.650347.55","article-title":"Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence","volume":"329","author":"Ram","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2014.03.034_bib0205","first-page":"CD003573","article-title":"Hospital at home for acute exacerbations of chronic obstructive pulmonary disease","volume":"5","author":"Jeppesen","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2014.03.034_bib0210","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1089\/tmj.2012.0005","article-title":"A home telemonitoring program reduced exacerbation and healthcare utilization rates in COPD patients with frequent exacerbations","volume":"18","author":"Alrajab","year":"2012","journal-title":"Telemed J"},{"key":"10.1016\/j.lpm.2014.03.034_bib0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1472-6963-13-82","article-title":"Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial","volume":"13","author":"Pedone","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.lpm.2014.03.034_bib0220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.rmed.2013.12.003","article-title":"A home telehealth program for patients with severe COPD: the PROMETE study","volume":"108","author":"Segrelles Calvo","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2014.03.034_bib0225","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1136\/bmj.f6070","article-title":"Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial","volume":"347","author":"Pinnock","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2014.03.034_bib0230","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.rmr.2012.05.012","article-title":"[Position of the French Language Society of Pulmonology regarding the 2011 version of the GOLD document]","volume":"29","author":"Roche","year":"2012","journal-title":"Rev Mal Respir"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214004631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214004631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T14:11:07Z","timestamp":1689603067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214004631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0755498214004631"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.034","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge des exacerbations\u00a0: de la ville \u00e0 l\u2019h\u00f4pital","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}